Enhancement of polysialic acid expression improves function of embryonic stem-derived dopamine neuron grafts in Parkinsonian mice

Stem Cells Translational Medicine

Volumn 3, Issue 1, 2014, Pages 108-113

  Battista, Daniela ^a,b   Ganat, Yosif ^a,b   Maarouf, Abderrahman El ^a   Studer, Lorenz ^a,b   Rutishauser, Urs ^a  

^a The Center for Stem Cell Biology   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Brain tissue transplantation; Dopaminergic neurons; Embryonic stem cells; Neuronal plasticity; Parkinson disease; Sialic acids

Indexed keywords

GREEN FLUORESCENT PROTEIN; NERVE CELL ADHESION MOLECULE; NEUROTROPHIC FACTOR; POLYSIALIC ACID; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DNA MODIFICATION; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENETIC TRANSDUCTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE FIBER GROWTH; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BRAIN TISSUE TRANSPLANTATION; DOPAMINERGIC NEURONS; EMBRYONIC STEM CELLS; NEURONAL PLASTICITY; PARKINSON DISEASE; SIALIC ACIDS;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINERGIC NEURONS; EMBRYONIC STEM CELLS; MICE; NEURAL STEM CELLS; NEURITES; PARKINSONIAN DISORDERS; PHENOTYPE; SIALIC ACIDS; SIALYLTRANSFERASES;

EID: 84892686541     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0084     Document Type: Article

References (21)

1. Lindvall O, Kokaia Z. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci 2009;30: 260-267.
2. Kriks S, Shim JW, Piao J et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011;480:547-551.
3. Rutishauser U. Polysialic acid in the plasticity of the developing and adult vertebrate nervous system. Nat Rev Neurosci 2008;9:26-35.
4. El Maarouf A, Petridis AK, Rutishauser U. Use of polysialic acid in repair of the central nervous system. Proc Natl Acad Sci USA 2006;103: 16989-16994.
5. Nakayama J, Angata K, Ong E et al. Polysialic acid, aunique glycanthat isdevelopmentally regulated by two polysialyltransferases, PST and STX, in the central nervous system: From biosynthesis to function. Pathol Int 1998;48:665-677.
6. Angata K, Fukuda M. Polysialyltransferases: Major players in polysialic acid synthesis on the neural cell adhesion molecule. Biochimie 2003;85:195-206.
7. Ganat YM, Calder EL, Kriks S et al. Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment. J Clin Invest 2012;122:2928-2939.
8. El Maarouf A, Rutishauser U. Removal of polysialic acid induces aberrant pathways, synaptic vesicle distribution, and terminal arborization of retinotectal axons. J Comp Neurol 2003;460: 203-211.
9. Hallenbeck PC, Vimr ER, Yu F et al. Purification and properties of a bacteriophage-induced endo-N-acetylneuraminidase specific for polyalpha-2,8-sialosyl carbohydrate units. J Biol Chem 1987;262:3553-3561.
10. Vimr ER, McCoy RD, Vollger HF et al. Use of prokaryotic-derived probes to identify poly (sialic acid) in neonatal neuronal membranes. Proc Natl Acad Sci USA 1984;81:1971-1975.
11. Tabar V, Tomishima M, Panagiotakos G et al. Therapeutic cloning in individual parkinsonian mice. Nat Med 2008;14:379-381.
12. Ghosh M, Tuesta LM, Puentes R et al. Extensive cell migration, axon regeneration, and improved function with polysialic acidmodified Schwann cells after spinal cord injury. Glia 2012;60:979-992.
13. Tang J, Landmesser L. Reduction of intramuscular nerve branching and synaptogenesis is correlated with decreased motoneuron survival. J Neurosci 1993;13:3095-3103.
14. Gascon E, Vutskits L, Jenny B et al. PSANCAM in postnatally generated immature neurons of the olfactory bulb: A crucial role in regulating p75 expression and cell survival. Development 2007;134:1181-1190.
15. Heuer A, Smith GA, Lelos MJ et al. Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: Motor impairments identify extent of dopamine depletion at three different lesion sites. Behav Brain Res 2012;228:30-43.
16. Smith GA, Heuer A, Dunnett SB et al. Unilateral nigrostriatal 6-hydroxydopamine lesions in mice II: Predicting l-DOPA-induced dyskinesia. Behav Brain Res 2012;226:281-292.
17. Redmond DE Jr, Elsworth JD, Roth RH et al. Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non-human primate after overexpression of GDNF. J Comp Neurol 2009;515:31-40.
18. Elsworth JD, Redmond DE Jr, Leranth C et al. AAV2-mediated gene transfer of GDNF to the striatum of MPTP monkeys enhances the survival and outgrowth of co-implanted fetal dopamine neurons. Exp Neurol 2008;211: 252-258.
19. Georgievska B, Kirik D, Björklund A. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp Neurol 2002;177:461-474.
20. Sautter J, Tseng JL, Braguglia D et al. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts. Exp Neurol 1998;149:230-236.
21. El Maarouf A, Moyo-Lee Yaw D, Lindhout T et al. Enzymatic engineering of polysialic acid on cells in vitro and in vivo using a purified bacterial polysialyltransferase. J Biol Chem 2012; 287:32770-32779.